AQR Capital Management
AMED

AQR Capital Management’s Amedisys AMED Stock Holding History

AQR Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-33,735
Closed -$3.31M – 3463
2025
Q2 		$3.31M Buy
33,735
+20,325
+152% +$1.92M ﹤0.01% 1492
2025
Q1 		$1.24M Buy
13,410
+6,646
+98% +$613K ﹤0.01% 1889
2024
Q4 		$614K Sell
6,764
-406
-6% -$37.3K ﹤0.01% 2146
2024
Q3 		$692K Buy
7,170
+516
+8% +$50.3K ﹤0.01% 2029
2024
Q2 		$611K Sell
6,654
-1,014
-13% -$94.1K ﹤0.01% 1965
2024
Q1 		$707K Sell
7,668
-268
-3% -$25.1K ﹤0.01% 1827
2023
Q4 		$754K Buy
7,936
+1,124
+17% +$105K ﹤0.01% 1710
2023
Q3 		$636K Buy
6,812
+1,897
+39% +$175K ﹤0.01% 1767
2023
Q2 		$449K Sell
4,915
-22,778
-82% -$1.87M ﹤0.01% 1822
2023
Q1 		$2.02M Buy
+27,693
New +$2.4M ﹤0.01% 1252
2022
Q4 		– Sell
-3,178
Closed -$308K – 2201
2022
Q3 		$308K Sell
3,178
-4,449
-58% -$531K ﹤0.01% 1936
2022
Q2 		$802K Buy
7,627
+1,967
+35% +$251K ﹤0.01% 1505
2022
Q1 		$975K Buy
5,660
+612
+12% +$91.4K ﹤0.01% 1549
2021
Q4 		$817K Sell
5,048
-21,136
-81% -$3.4M ﹤0.01% 1650
2021
Q3 		$3.9M Buy
26,184
+19,461
+289% +$4.05M 0.01% 875
2021
Q2 		$1.65M Sell
6,723
-1,375
-17% -$361K ﹤0.01% 1329
2021
Q1 		$2.14M Sell
8,098
-3,259
-29% -$919K ﹤0.01% 1172
2020
Q4 		$3.25M Buy
11,357
+3,695
+48% +$947K 0.01% 936
2020
Q3 		$1.8M Sell
7,662
-39,512
-84% -$8.98M ﹤0.01% 1155
2020
Q2 		$9.37M Sell
47,174
-13,465
-22% -$2.51M 0.02% 648
2020
Q1 		$11.1M Sell
60,639
-14,987
-20% -$2.67M 0.02% 599
2019
Q4 		$12.6M Sell
75,626
-90,529
-54% -$13.5M 0.01% 695
2019
Q3 		$21.8M Sell
166,155
-63,306
-28% -$8.24M 0.03% 568
2019
Q2 		$27.8M Buy
229,461
+67,602
+42% +$8.02M 0.03% 518
2019
Q1 		$20M Buy
161,859
+44,819
+38% +$5.63M 0.02% 605
2018
Q4 		$13.7M Buy
117,040
+80,926
+224% +$9.54M 0.02% 640
2018
Q3 		$4.51M Buy
36,114
+17,601
+95% +$1.94M ﹤0.01% 1051
2018
Q2 		$1.58M Sell
18,513
-390
-2% -$28.6K ﹤0.01% 1532
2018
Q1 		$1.14M Buy
+18,903
New +$1.08M ﹤0.01% 1624
2017
Q1 		– Sell
-10,901
Closed -$465K – 2173
2016
Q4 		$465K Sell
10,901
-27,872
-72% -$1.19M ﹤0.01% 1960
2016
Q3 		$1.84M Sell
38,773
-46,384
-54% -$2.31M ﹤0.01% 1449
2016
Q2 		$4.3M Sell
85,157
-65,170
-43% -$3.29M 0.01% 967
2016
Q1 		$7.27M Buy
150,327
+18,099
+14% +$698K 0.01% 763
2015
Q4 		$5.2M Buy
132,228
+10,718
+9% +$429K 0.01% 901
2015
Q3 		$4.61M Buy
121,510
+44,929
+59% +$1.89M 0.01% 836
2015
Q2 		$3.04M Buy
76,581
+32,950
+76% +$1.03M 0.01% 1006
2015
Q1 		$1.17M Buy
43,631
+17,455
+67% +$492K ﹤0.01% 1343
2014
Q4 		$768K Buy
+26,176
New +$646K ﹤0.01% 1774
2014
Q2 		– Sell
-94,876
Closed -$1.41M – 2512
2014
Q1 		$1.41M Sell
94,876
-200
-0.2% -$3.08K ﹤0.01% 1507
2013
Q4 		$1.39M Sell
95,076
-61,924
-39% -$997K ﹤0.01% 1563
2013
Q3 		$2.7M Sell
157,000
-231,480
-60% -$3.43M 0.01% 1098
2013
Q2 		$4.51M Buy
+388,480
New +$4.45M 0.02% 909

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AQR Capital Management's AMED Position: Q3 2025 in Review

AQR Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 33,735 shares — an estimated $3.31M sold.

AQR Capital Management first reported a position in AMED in Q2 2013 and held it in 42 quarters. The position peaked at $27.8M in Q2 2019. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • AQR Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • AQR Capital Management sold 33,735 Amedisys shares in Q3 2025, an estimated $3.31M.
  • AQR Capital Management first reported a position in Amedisys in Q2 2013 and held it in 42 quarters.
  • AQR Capital Management's Amedisys position peaked at $27.8M in Q2 2019.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on AQR Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.